LiveActive security incident?Get immediate response
CVE Record

CVE-2020-5662: Reflected cross-site scripting vulnerability in XooNIps 3.49 and earlier allows remote authenticated attack...

Reflected cross-site scripting vulnerability in XooNIps 3.49 and earlier allows remote authenticated attackers to inject arbitrary script via unspecified vectors.

UnknownCVSS not scoredNot KEV-listedUpdated
Glexia's TakeAutomated analysismoderate

Security readout for executives and security teams

Plain-English summary

XooNIps 3.49 and earlier has a reflected cross-site scripting issue. An authenticated attacker could cause script to run in another user’s browser through unspecified input. Business risk depends on whether XooNIps is exposed to untrusted authenticated users and what privileges those users hold.

Executive priority

Treat this as a targeted remediation item, not an emergency, unless XooNIps is public-facing or used by untrusted authenticated users. The main action is confirming whether affected versions exist and following vendor guidance.

Technical view

CVE-2020-5662 is a reflected XSS vulnerability in XooNIps 3.49 and earlier. The public description says remote authenticated attackers can inject arbitrary script through unspecified vectors. The source bundle provides no CVSS score, CWE, affected endpoint, exploit detail, or confirmed fixed version.

Likely exposure

Exposure is likely limited to organizations running XooNIps 3.49 or earlier, especially internet-facing or partner-facing deployments with multiple authenticated users. Because the vector is unspecified, version inventory is more reliable than path-specific scanning from the supplied evidence.

Exploitation context

The source bundle says this is not in KEV and provides no evidence of active exploitation. Authentication is required, which lowers opportunistic risk, but reflected XSS can still matter where attackers can reach logged-in users.

Researcher notes

Evidence is thin: vectors are unspecified, CVSS is absent, and no exploit status or fixed release is included in the supplied bundle. Avoid endpoint assumptions. Focus validation on asset discovery, version confirmation, and advisory review.

Mitigation direction

  • Identify all XooNIps deployments and record their versions.
  • Review the XooNIps and JVN advisories for vendor-confirmed remediation guidance.
  • Prioritize upgrading or replacing versions 3.49 and earlier if vendor guidance supports it.
  • Restrict XooNIps access to trusted users while remediation is planned.
  • Monitor for suspicious authenticated activity involving XooNIps pages.

Validation and detection

  • Confirm whether XooNIps is deployed in production or externally reachable environments.
  • Verify installed versions and flag 3.49 or earlier.
  • Check vendor and JVN advisories for fixed-version or workaround details.
  • Review authentication boundaries and user populations for exposed XooNIps instances.
  • Document uncertainty where endpoint and vector details are unavailable.
Prepared
Confidence
medium
Sources
4

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cve · low confidence lookup

CVE-2020-5662 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Unknown
CVSS
Not scored
Known Exploited
No
Published
Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

0CVSS vectors
0Timeline events
0ADP providers
3Source links

CVSS and timeline data

No CVSS vectors or timeline events were available in the normalized CVE source material.

Source materials

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
Neuroinformatics Unit, Integrative Computational Brain Science Collaboration Division, RIKEN Center for Brain ScienceXooNIps3.49 and earlierListed
Weakness

CWE details

No CWE listed

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.